Healthcare · Medical - Healthcare Information Services
Price
$15.21
Market Cap
$28.4M
Employees
117
Beta
0.64
Avg Volume
117,291
CEO
Alfred Lim
Business Description
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
Business History
Price Overview
Last updated: Jun 27, 2026 10:49am (just now)$15.21
+0.62 (+4.25%)
Day Range
$14.87 – $15.36
52-Week Range
$5.26 – $86.00
50-Day MA
$14.35
200-Day MA
$29.93
Volume
4,752.00
Share Structure
Outstanding
1,867,542.00
Float
941,213.00
Free Float
50.4%
Normal free float
— 50.4% of shares trade freely, ~49.6% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Small absolute float (0.9M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-10.21
Stock Price: $15.21
EPS (Diluted): -1.49
EPS (Diluted): -1.49
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
-20.17
Stock Price: $15.21
Total Equity: -$4.25M
Shares: 1,857,818
Total Equity: -$4.25M
Shares: 1,857,818
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-20.10
Market Cap: $28.41M
Total Debt: $2.20M
Cash: $345,145
EBITDA: -$2.09M
Total Debt: $2.20M
Cash: $345,145
EBITDA: -$2.09M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$87.9M
Market Cap: $28.41M
Total Debt: $2.20M
Cash: $345,145
Total Debt: $2.20M
Cash: $345,145
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
12.59
Stock Price: $15.21
Revenue: $6.82M
Shares: 1,857,818
Revenue: $6.82M
Shares: 1,857,818
EV/Sales (Total value vs revenue — works when P/E can't)
API12.89
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
43.9%
Gross Profit: $2.99M
Revenue: $6.82M
Revenue: $6.82M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-35.8%
Operating Income: -$2.44M
Revenue: $6.82M
Revenue: $6.82M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-40.7%
Net Income: -$2.77M
Revenue: $6.82M
Revenue: $6.82M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
13.2%
Net Income: -$2.77M
Total Equity: -$4.25M
Total Equity: -$4.25M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
91.2%
Operating Income: -$2.44M
Tax Rate: -1.5%
Equity: -$4.25M
Total Debt: $2.20M
Cash: $345,145
Tax Rate: -1.5%
Equity: -$4.25M
Total Debt: $2.20M
Cash: $345,145
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
0.18
Current Assets: $1.04M
Current Liabilities: $5.84M
Current Liabilities: $5.84M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
-0.52
Short-Term Debt: $2.20M
Long-Term Debt: $0.00
Total Debt: $2.20M
Total Equity: -$4.25M
Long-Term Debt: $0.00
Total Debt: $2.20M
Total Equity: -$4.25M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$3.67
Revenue: $6.82M
Shares: 1,857,818
Shares: 1,857,818
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$-2.29
Total Equity: -$4.25M
Shares: 1,857,818
Shares: 1,857,818
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-1.36
Operating CF: -$2.43M
CapEx: -$104,450
Shares: 1,857,818
CapEx: -$104,450
Shares: 1,857,818
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $15.21
Stock Price: $15.21
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$2.77M
Net Income: -$2.77M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares EUDA against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 26, 2026 8:20pm (14h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.6M | $3.8M | $3.7M | $4.0M | $6.8M |
| Cost of Revenue | $3.3M | $2.9M | $2.9M | $3.2M | $3.8M |
| Gross Profit | $1.2M | $869,999 | $842,075 | $762,155 | $3.0M |
| Operating Expenses | $1.8M | $13.1M | $4.8M | $18.1M | $5.4M |
| Operating Income | $-559,993 | -$5.7M | -$4.0M | -$17.3M | -$2.4M |
| Net Income | $864,829 | -$24.9M | -$10.0M | -$15.4M | -$2.8M |
| EBITDA | $1.3M | -$24.6M | -$8.3M | -$17.4M | -$2.1M |
| EPS | $1.87 | $-41.40 | $-7.40 | $-9.40 | $-1.49 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 26, 2026 8:20pm (14h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $189,996 | $57,541 | $189,005 | $237,605 | $345,145 |
| Total Current Assets | $4.4M | $25.0M | $723,441 | $762,876 | $1.0M |
| Total Assets | $8.0M | $25.6M | $1.3M | $1.7M | $1.7M |
| Current Liabilities | $7.3M | $29.1M | $8.7M | $4.1M | $5.8M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.4M | $29.1M | $8.8M | $4.3M | $6.0M |
| Total Equity | $521,232 | -$3.5M | -$7.5M | -$2.6M | -$4.3M |
| Retained Earnings | $180,333 | -$24.7M | -$34.7M | -$50.1M | -$52.9M |
Cash Flow (Annual)
Last updated: Jun 26, 2026 8:20pm (14h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $443,920 | -$1.5M | -$2.9M | -$2.0M | -$2.4M |
| Capital Expenditure | $-1,957 | $-18,137 | $-5 | $-116,030 | $-104,450 |
| Free Cash Flow | $441,963 | -$1.5M | -$2.9M | -$2.2M | -$2.5M |
| Acquisitions (net) | $-354,226 | $-3,405 | $0 | $16,297 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-60,771 | $594,489 | $-586,931 | $40,051 | $107,540 |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 8:20pm (14h ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue |
$11.8M $11.8M – $11.8M
|
$5.1M $5.1M – $5.1M
|
$9.3M $9.3M – $9.3M
|
$27.2M $27.2M – $27.2M
|
| EBITDA |
-$6.6M -$6.6M – -$6.6M
|
-$3.1M -$3.1M – -$3.1M
|
-$5.6M -$5.6M – -$5.6M
|
-$16.4M -$16.4M – -$16.4M
|
| Net Income | $0 |
-$1.1M -$1.1M – -$1.1M
|
$743,127 $743,127 – $743,127
|
$3.0M $3.0M – $3.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 26, 2026 8:20pm (14h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -17.4% | -1.5% | +8.2% | +70.0% |
| Gross Profit Growth | -30.4% | -3.2% | -9.5% | +292.7% |
| Operating Income Growth | -921.3% | +30.7% | -337.6% | +85.9% |
| Net Income Growth | -2,977.3% | +59.7% | -53.0% | +81.9% |
| EBITDA Growth | -1,932.8% | +66.2% | -109.9% | +88.0% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 10:08am (41m ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-03-18 | Tay Whye Shin | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Liew Kwong Yeow | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Lew Chern Yong | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Huang Bo | 0.00 | $0.00 | $0 | |
| 2023-06-12 | Chen Wei Wen Kelvin | J-Other | 271,867.00 | $0.00 | $0 |
| 2023-05-22 | Wong KongYew | 0.00 | $0.00 | $0 | |
| 2023-05-16 | Chen Wei Wen Kelvin | J-Other | 850,306.00 | $850,306.00 | $723.0B |
| 2023-05-22 | Rajpal Ajay | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Tan Meng Dong (James) | J-Other | 2,776,000.00 | $0.00 | $0 |
| 2021-11-24 | Tan Meng Dong (James) | P-Purchase | 292,250.00 | $0.00 | $0 |
| 2021-11-24 | Tan Meng Dong (James) | J-Other | 3,000.00 | $0.00 | $0 |
| 2022-11-17 | Chan Kim Hing | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Chan Kim Hing | — | — | — | |
| 2022-11-17 | Liew Kwong Yeow | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Chen Wei Wen Kelvin | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Tan Daniel | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Tan Daniel | — | — | — | |
| 2022-11-17 | Arrow Alexander K. | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Capes David Francis | 0.00 | $0.00 | $0 | |
| 2022-11-17 | Capes David Francis | — | — | — |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for EUDA — it's generated by the pipeline (
market-narrative step).
No community reviews yet for EUDA.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30